Android app on Google Play

Optimer Pharma (OPTR) Said to Draw Interest from Glaxo (GSK), Astellas

April 2, 2013 9:33 AM EDT Send to a Friend
Optimer Pharmaceuticals, Inc. (Nasdaq: OPTR) said to draw interest from Glaxo (NYSE: GSK), Astellas, Cubist (Nasdaq: CBST), AstraZeneca (NYSE: AZN). Optimer might go for about $1 billion, according to reports.

Shares are ripping early.




You May Also Be Interested In


Related Categories

Momentum Movers, Rumors, Trader Talk

Add Your Comment